Ping An Insurance Group's technology arm, Ping An Technology, has completed a prospective multi-centre clinical trial for the world's first intelligent optical coherence tomography (OCT) retinal disease screening system. This development comes amidst Ping An's constant advancements in leveraging AI and its strong medical repository to establish a healthcare ecosystem.
The technology team of bio ##tech Insurance Group has completed clinical trials for its retinal disease screening system . The intelligent optical imaging tomography ( OCT ) system is believed to be the first to integrate AI detection in an integrated retinal imaging device , and was jointly developed with cloud - based Optovue .